Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/8EG stock hub

FRA/8EG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/8EGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

302.9M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/8EGFRA/8EG

—

Loading chart…

In the news

Latest news · FRA/8EG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE1.7

P25 n/aP50 n/aP75 n/a

ROIC2.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/8EG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

JPY

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	DE
Employees	793
Employees Change	51%
Employees Change Percent	6.03
Enterprise value	EUR 325.1M
Exchange	Frankfurt Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 302.9M
Price	EUR 2.16
Price currency	EUR
Rev Per Employee	345,042.5x
Sic	2834
Symbol	fra/8EG
Website	https://www.euglena.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.44%
EV Earnings	-74.34x
EV/EBIT	19.36x
EV/EBITDA	9.3x
EV/FCF	12.02x
EV/Sales	1.19x
FCF yield	8.93%
P/B ratio	1.95x
P/S ratio	1.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.2%
EBITDA Margin	12.85%
FCF margin	9.88%
Gross margin	69.55%
Gross Profit	EUR 190.3M
Gross Profit Growth	5.31%
Gross Profit Growth Q	6.47%
Gross Profit Growth3 Y	4.17%
Gross Profit Growth5 Y	30.44%
Net Income	EUR -4.4M
Pretax Margin	3.75%
Profit Margin	-1.6%
Profit Per Employee	EUR -5,514
ROA	2.68
ROCE	5.35
ROE	1.73
ROIC	2.45
Roic5y	-5.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-15.89%
Cagr1y	-20.6%
Cagr3y	-28.46%
Cagr5y	-20.5%
FCF Growth	123.68%
FCF Growth3 Y	103.02%
OCF Growth	96.14%
OCF Growth10 Y	32.08%
OCF Growth3 Y	77.74%
Revenue Growth	5.78x
Revenue Growth Q	7.61x
Revenue Growth3 Y	4.3x
Revenue Growth5 Y	30.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.69
Assets	EUR 392.9M
Cash	EUR 115M
Current Assets	EUR 181M
Current Liabilities	EUR 75.7M
Debt	EUR 150.4M
Debt EBITDA	EUR 4.28
Debt Equity	EUR 0.97
Debt FCF	EUR 5.56
Equity	EUR 155M
Interest Coverage	6.72
Liabilities	EUR 238M
Long Term Assets	EUR 211.9M
Long Term Liabilities	EUR 162.3M
Net Cash	EUR -35.4M
Net Cash By Market Cap	EUR -11.69
Net Debt EBITDA	EUR 1.01
Net Debt Equity	EUR 0.23
Net Debt FCF	EUR 1.31
Tangible Book Value	EUR -38,025
Tangible Book Value Per Share	EUR -0

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.39
Inventory Turnover	3.91
Net Working Capital	EUR 12.2M
Quick ratio	1.86
Working Capital	EUR 105.7M
Working Capital Turnover	EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.63%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	EUR 0.01
Dividend Years	1
Dividend Yield	0.5%
Ex Div Date	2025-12-29
Last Dividend	EUR 0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-82.28%
1Y total return	-20.59%
200-day SMA	2.33
3Y total return	-63.39%
50-day SMA	2.1
50-day SMA vs 200-day SMA	50under200
5Y total return	-68.24%
All Time High	22.24
All Time High Change	-90.29%
All Time High Date	2013-05-07
All Time Low	1.93
All Time Low Change	11.92%
All Time Low Date	2026-03-04
ATR	0.03
Ch YTD	0.93
High	2.16
High52	2.92
High52 Date	2025-08-06
High52ch	-26.03%
Low	2.16
Low52	1.93
Low52 Date	2026-03-04
Low52ch	11.92%
Ma50ch	2.91%
Price vs 200-day SMA	-7.18%
RSI	51.86
RSI Monthly	32.76
RSI Weekly	45.66
Sharpe ratio	-0.54x
Sortino ratio	-0.67
Total Return	-1.13%
Tr YTD	0.93
Tr1m	-3.57%
Tr3m	-0.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 17M
Operating Income Growth	934.4
Operating Income Growth Q	254.9
Operating margin	6.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	104,731,540%
Net Borrowing	9,466,601.7
Shares Insiders	10.42%
Shares Institutions	3.64%
Shares Qo Q	0%
Shares Yo Y	1.63%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 27M
Average Volume	675.7x
Bv Per Share	1.23
CAPEX	EUR -1.1M
Ch10y	-82.28
Ch1m	-3.57
Ch1y	-20.59
Ch3m	-0.92
Ch3y	-63.39
Ch5y	-68.24
Ch6m	-8.47
Change	-0.92%
Change From Open	0
Close	2.18
Days Gap	-0.92
Depreciation Amortization	18,115,903.9
Earnings Date	2026-05-14
EBIT	EUR 17M
EBITDA	EUR 35.2M
EPS	EUR -0.03
F Score	3
FCF	EUR 27M
FCF EV Yield	8.32x
Financing CF	-13,189,323
Fiscal Year End	December
Founded	2,005
Goodwill	60,117,521.6
Income Tax	EUR 7.4M
Investing CF	-3,177,823
Is Primary Listing	0
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Last Split Date	2013-09-26
Last Split Type	Forward
Ma150	2.22
Ma150ch	-2.53%
Ma20	2.15
Ma20ch	0.28%
Net CF	11,798,686
Next Earnings Date	2026-05-14
Open	2.16
P FCF Ratio	11.2
P OCF Ratio	10.75
Payment Date	2026-03-25
Ppne	31,122,332.7
Price Date	2026-05-08
Price EBITDA	EUR 8.62
Relative Volume	19.84x
Revenue	273,618,705x
Tax By Revenue	2.71x
Tax Rate	72.15%
Tr6m	-8.47%
Volume	0
Z Score	1.93

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/8EG dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.01 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-1.1%

Next ex-dividend date: 2025-12-29

Performance

FRA/8EG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/8EG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.6%

Share of float held by funds and institutions

Insider ownership

+10.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.6%

Negative means the company is buying back shares.

Technical

FRA/8EG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.9

Neutral momentum band

Price vs 200-day MA

-7.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/8EG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/8EG stock rating?

fra/8EG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/8EG analysis?

The full report lives at /stocks/fra/8EG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/8EG?

The latest report frames fra/8EG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/8EG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.